19:50 EST Oncternal Therapeutics trading halted, news pending
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ONCT:
- Oncternal Therapeutics Announces Reverse Stock Split
- Oncternal Therapeutics to effect 1-for-20 reverse stock split
- Oncternal Therapeutics reports inducement award under Nasdaq listing rule
- Oncternal Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
- Oncternal Therapeutics Updates the Status of its Phase 1/2 Study of ONCT-808, a ROR1-Targeting Autologous CAR T, in Patients with Relapsed or Refractory Aggressive B-cell Lymphoma